Harneys advises Mobile-health Network Solutions on NASDAQ listing

Ranked 41 out of 500 by the Financial Times in the “High-Growth Companies Asia-Pacific 2024” category, Mobile-health provides personalised medical services to users and healthcare providers globally via its MaNaDr platform. The platform gives users access to virtual clinics and a global network of peer-to-peer support groups and partners. The IPO proceeds will primarily be used for product development and business expansion.

Partner Lishi Fong led the Harneys team with support from Associate Jonathan Lim. Lishi said: "The telehealth sector holds immense promise for revolutionising global healthcare services and we are delighted to have represented Mobile-heath on their Nasdaq listing. We wish the company success in their global expansion plans. This deal underscores our expertise advising on IPOs in the healthcare sector."

The Corporate team at Harneys has a leading Equity Capital Markets practice with substantial experience in all aspects of capital raising by offshore companies, including IPOs and secondary offerings, rights issues, equity-linked securities, including convertible and exchangeable bonds, SPACs, and business combinations, as well as private placements, take-privates, takeovers, and spin-offs. The firm’s ECM expertise lies in advising entities listed or listing on all major stock exchanges, including the New York Stock Exchange, NASDAQ, the London Stock Exchange, AIM, the Bermuda Stock Exchange, the Hong Kong Stock Exchange, the Shanghai Stock Exchange, and the Luxembourg Stock Exchange.